Systemic Medications and Their Ocular Side Effects
- PMID: 39744265
- PMCID: PMC11692015
- DOI: 10.7759/cureus.74976
Systemic Medications and Their Ocular Side Effects
Abstract
Most of the drugs that we use in our everyday clinic cause ocular side effects or toxicity, depending on the drug duration and dose. Eye care physicians should be familiar with any possible ocular side effects linked to these medications, which could save the physicians' time to determine the diagnosis of the ocular irritation or toxicity. Not all medications are listed in this review, but we did go over the most common systemic medications based on our experience seeing patients in our everyday clinic. The ocular adverse effects of the most common drugs used are reviewed in this review article.
Keywords: antituberculous ocular toxicity; ocular toxicity; retinal toxicity; systemic medication; tamoxifen ocular toxicity; visual field defect.
Copyright © 2024, Al-Namaeh et al.
Conflict of interest statement
Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
References
-
- King GS, Goyal A, Grigorova Y, Patel P, Hashmi MF. StatPearls Publishing, Treasure Island. Treasure Island, FL: StatPearls Publishing; 2024. Antiarrhythmic medications. - PubMed
-
- Ocular adverse effects of amiodarone: a systematic review of case reports. Alshehri M, Joury A. Optom Vis Sci. 2020;97:536–542. - PubMed
-
- Bilateral angle-closure glaucoma and ciliary body swelling from topiramate. Rhee DJ, Goldberg MJ, Parrish RK. https://pubmed.ncbi.nlm.nih.gov/11709030/ Arch Ophthalmol. 2001;119:1721–1723. - PubMed
-
- Vigabatrin as add-on therapy for adult complex partial seizures: a double-blind, placebo-controlled multicentre study. The Canadian Vigabatrin Study Group. Bruni J, Guberman A, Vachon L, Desforges C. Seizure. 2000;9:224–232. - PubMed
Publication types
LinkOut - more resources
Full Text Sources